ایران دارو
دیران | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 22,480 2.98
Close Price: 22,480
Income Statement
AGM
Interim
2026/05/20 Fiscal Year 2025/12/2112 Month | 2025/04/20 Fiscal Year 2024/12/2012 Month | 2024/04/17 Fiscal Year 2023/12/2112 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 8.635 Trillion | 5.811 Trillion | 5.262 Trillion | |
Total Revenues | 8.635 Trillion | 5.811 Trillion | 5.262 Trillion | |
Cost of Goods Sold | 5.226 Trillion | 4.171 Trillion | 3.328 Trillion | |
Gross Profit | 3.409 Trillion | 1.64 Trillion | 1.934 Trillion | |
General & Administrative Expenses | 701.807 Billion | 412.046 Billion | 224.859 Billion | |
Net Operating Income & Expenses | 24.102 Billion | 19.367 Billion | 6.391 Billion | |
Operating Profit (Loss) | 2.732 Trillion | 1.247 Trillion | 1.716 Trillion | |
Profit Before Tax | 757.074 Billion | 117.759 Billion | 1.123 Trillion | |
Tax | 393.609 Billion | 100.251 Billion | 196.06 Billion | |
Net Profit (Loss) After Tax | 363.465 Billion | 17.508 Billion | 927.009 Billion | |
Retained Earnings at Beginning of Period | 380.519 Billion | 1.024 Trillion | 646.051 Billion | |
Approved Dividends — Prior Year AGM | -16.02 Billion | -646.8 Billion | -536.8 Billion | |
Capital Decrease (Increase) from Accumulated Losses (Retained Earnings) | -65.288 Billion | - | - | |
Transfer from Other Equity Items | - | -13.259 Billion | -12.315 Billion | |
Allocable Profit | 662.676 Billion | 381.394 Billion | 1.024 Trillion | |
Legal Reserve | 18.173 Billion | 875 Million | 88 Billion | |
Other Reserves | - | - | 39 Million | |
Approved Dividends — Current Year | 53.4 Billion | 16.02 Billion | 646.8 Billion | |
Retained Earnings at End of Period | 591.103 Billion | 364.499 Billion | 289.106 Billion |